Shanghai Pharmaceuticals (Germany) Today
| S1R Stock | EUR 1.58 0.01 0.63% |
Performance13 of 100
| Odds Of DistressLess than 9
|
Shanghai Pharmaceuticals is trading at 1.58 as of the 22nd of December 2024. This is a 0.63 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.57. Shanghai Pharmaceuticals has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. The performance scores are derived for the period starting the 28th of November 2023 and ending today, the 22nd of December 2024. Click here to learn more.
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the Peoples Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. The company has 919.07 M outstanding shares. More on Shanghai Pharmaceuticals Holding
Moving together with Shanghai Stock
| 0.71 | CLH | Cardinal Health | PairCorr |
| 0.64 | HS2 | Henry Schein | PairCorr |
| 0.89 | X2S | Sinopharm Group | PairCorr |
| 0.94 | X2S1 | SINOPHARM GROUP 15ON | PairCorr |
Moving against Shanghai Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Shanghai Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Shanghai Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Shanghai Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President | Bo Shen |
| Business Concentration | Medical Distribution, Healthcare (View all Sectors) |
Shanghai Pharmaceuticals Holding (S1R) is traded on Frankfurt Exchange in Germany and employs 47,056 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.17 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shanghai Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Shanghai Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Shanghai Pharmaceuticals classifies itself under Healthcare sector and is part of Medical Distribution industry. The entity has 919.07 M outstanding shares.
Shanghai Pharmaceuticals Holding has accumulated about 23.68 B in cash with 5.06 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.33, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Shanghai Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationShanghai Pharmaceuticals shows a total of 919.07 Million outstanding shares. Shanghai Pharmaceuticals maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Shanghai Ownership Details
Shanghai Pharmaceuticals Risk Profiles
Although Shanghai Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Shanghai Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.39 | |||
| Semi Deviation | 2.63 | |||
| Standard Deviation | 3.31 | |||
| Variance | 10.97 |
Shanghai Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Shanghai Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Shanghai Pharmaceuticals Corporate Management
Elected by the shareholders, the Shanghai Pharmaceuticals' board of directors comprises two types of representatives: Shanghai Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shanghai. The board's role is to monitor Shanghai Pharmaceuticals' management team and ensure that shareholders' interests are well served. Shanghai Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shanghai Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jun Zhou | Chairman of the Board, Non-Executive Director | Profile | |
| Dawei Liu | Vice President Secretary of the Board | Profile | |
| Haoliang Gu | Vice President | Profile | |
| Liang Hong | Independent Non-Executive Director | Profile | |
| Ying Ke | Director Center | Profile | |
| Yong Zhao | Vice President | Profile | |
| Tao Zhong | Board VP | Profile |
Other Information on Investing in Shanghai Stock
Shanghai Pharmaceuticals financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Pharmaceuticals security.